Table 1. Single-cell MYD88 sequencing of... | American Society of Hematology

Table 1.

Single-cell MYD88 sequencing of CD19⁺CD20⁺ B cells isolated from patients with DLBCL or chronic inflammation

Patient	Clinical diagnosis	MYD88^WT	MYD88^L265P homozygous	MYD88^L265P heterozygous
1*	DLBCL
a	Initial diagnosis	0	14	0
b	Disease recurrence	3	2	4
2†	DLBCL	1	4	4
3	DLBCL	5	2	3
4	Inflammation	5	0	0
5	Inflammation	0	1	21
6	Inflammation	0	0	13

Patient	Clinical diagnosis	MYD88^WT	MYD88^L265P homozygous	MYD88^L265P heterozygous
1*	DLBCL
a	Initial diagnosis	0	14	0
b	Disease recurrence	3	2	4
2†	DLBCL	1	4	4
3	DLBCL	5	2	3
4	Inflammation	5	0	0
5	Inflammation	0	1	21
6	Inflammation	0	0	13

1a and 1b are samples from the same patient, before and after (12 mo) intravitreal rituximab and methotrexate therapy, taken during initial diagnosis and disease recurrence, respectively.

†

Consisted of single cells isolated from both eyes and the aqueous humor.

View Large

This Feature Is Available To Subscribers Only